Keith Michael Gottesdiener

Insider Reports History

Location
900 Fifth Avenue, #8 C, New York, NY
Signature
/s/ Gil M. Labrucherie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Michael Gottesdiener:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Common Stock 2.31M $14.4M $6.25 Oct 8, 2024 Direct
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Common Stock 682K $4.26M $6.25 Oct 8, 2024 By Trust
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Common Stock 50.2K $314K $6.25 Oct 8, 2024 By Spouse
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Stock Option (right to buy) 300K May 8, 2025 Direct
Septerna, Inc. Director Stock Option (Right to Buy) 33.2K Sep 25, 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Keith Michael Gottesdiener

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SEPN Septerna, Inc. Sep 25, 2025 1 $0 4 Sep 29, 2025 Director
SEPN Septerna, Inc. Sep 25, 2025 0 $0 3 Sep 29, 2025 Director
PRME Prime Medicine, Inc. May 8, 2025 1 $0 4 May 12, 2025 Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Feb 28, 2025 1 $0 4 Mar 4, 2025 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Dec 5, 2024 1 $0 4 Dec 9, 2024 Officer, Director
PRME Prime Medicine, Inc. Oct 8, 2024 2 $0 4 Oct 10, 2024 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Feb 25, 2024 1 $0 4 Feb 27, 2024 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Nov 11, 2023 2 $0 4 Nov 14, 2023 Officer, Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 10 -$624K 4 Nov 13, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
PRME Prime Medicine, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 President and Chief Executive Officer. Exhibit 24 - Power of Attorney, Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director